Advertisement

The Body: The Complete HIV/AIDS Resource
Sign up for free e-mail updates!The Body en Espanol
DO. SEE. HEAR. KNOW. Visit TheBody.com's 2008 World AIDS Day Center >>
San Francisco AIDS Foundation
When Should Women Take Viral Load Tests?

Winter 2000


This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document.

Kathryn Anastos, M.D., proposed distinct timepoints for viral load testing to optimize the information such tests provide:
  • at serodiagnosis, to drive decisions about initial antiretroviral therapy;

  • before changing or starting any new antiretroviral therapy;

  • approximately four weeks after starting or changing antiretroviral therapy (look for at least a one-log or ten-fold decrease or, ideally, an undetectable viral load);

  • 12 weeks after switching or changing a regimen, which Dr. Anastos called "the best time to detect the viral load nadir [the lowest point to which the drug regimen will push the viral load]"; and

  • every 3-4 months in people on stable therapy or in those not taking any antiretroviral therapy [who, Dr. Anastos added, should be only those with high CD4 cell counts and no detectable viral load].

Dr. Anastos offered a suggestion for people looking to switch therapy because of unacceptable side effects: "Before switching, first achieve a very low viral load to minimize the possibility of viral rebound, because you get a better shot at suppressing the virus with a new regimen if you switch when viral load is low."


Back to the SFAF BETA Winter 2000 contents page.


This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document.

See Also
More on HIV Monitoring Tests
TheBody.com's HIV/AIDS Resource Center for Women
More on Women & HIV Treatment/
Complications


This article was provided by San Francisco AIDS Foundation. It is a part of the publication Bulletin of Experimental Treatments for AIDS.


Advertisement